EXCELSIOR Business Summary

Excelsior Medical Co., Ltd. (4104.TW) operates a vertically integrated healthcare business model, generating revenue through medical equipment distribution, consumables sales, and comprehensive clinical management services. The company’s operations are structured into four primary segments: the Excelsior segment, which dominates the hemodialysis and surgical equipment market; the Dynamic segment, focusing on aesthetic medicine and laser equipment leasing; the Arich segment, providing pharmaceutical logistics and wholesale distribution; and a diversified services segment encompassing long-term care facilities and health appliances. Excelsior distinguishes itself through a high-density downstream network, controlling the value chain from procurement to service delivery in dialysis and senior care. Its primary competitors include Hi-Clearance (1788.TW), CHC Healthcare Group (4164.TW), and Pacific Hospital Supply (4126.TW). Within this landscape, Excelsior maintains a leading market share in Taiwan’s dialysis sector, leveraging a hybrid revenue stream of one-time equipment sales and high-margin, recurring consumables and service fees. The company was founded in 1988 by Fu-Yuan Fu (傅輝東), who serves as Chairman and has been the primary architect of the group’s expansion into the broader Asia-Pacific region. The current executive leadership team is headed by Vice Chairman Chang Hsien-Cheng (張憲政) and General Manager Chang Ming-Cheng (張明正), both of whom bring decades of experience in medical marketing and healthcare operations. The board of directors includes key figures such as Fu Ruo-Xuan (傅若軒), who leads the group’s digital transformation and information engineering initiatives, and Chen Dun-Ling (陳敦領), a specialist in clinical medicine. Notable institutional investors and board representation from Excelsior Investment and Bestchain Healthtaiwan provide a stable governance framework. This leadership pedigree has successfully transitioned the firm from a traditional medical trader into a service-oriented healthcare conglomerate, supported by strategic international partnerships with brands such as Coway and Fresenius Medical Care.